O'Rourke et al. reported upregulation of PD-L1, IDO, and TGF-β, as well as FoxP3+ Tregs in resected tumors following EGFRvIII CAR T-cells, potentially reflecting tumor adaptation and immune evasion (181). The gene discussed is TGFB1; the disease is neoplasm.